Ikarian Capital, LLC
DALLAS, TX · CIK 1778253 · 13F filing filed 2022-05-13
SEC-registered investment adviser since 2020 · limited liability company
- Assets managed$698.0m
- Staff8 · 3 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds1 (1 hedge) · $564.0m gross assets
- Form ADV · 2026-05-20SEC adviser record
- Legal entityIKARIAN CAPITAL, LLC (US)
- Kindhedge funds, futures
- Others nearbyDallas, TX
As an employer
- Offices in1 country
- Private fundshedge 1
$328.7m
reported value
-5.9% vs Q4 2021
155positions
37.8%in top 10
16 new
124 added
11 reduced
10 sold out
vs Q4 2021
Options: 29 call positions ($347.7m notional), 12 put positions ($84.0m notional) – listed below, not included above.
Holdings, Q1 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BICYCLE THERAPEUTICS PLC BCYC | $21.0m6.39% | Reduced -134.3k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $18.3m5.57% | Added +118.7k |
| KEZAR LIFE SCIENCES INC COM | $18.0m5.48% | Added +62.2k |
| MILESTONE PHARMACEUTICALS IN MIST | $12.4m3.77% | Added +178.7k |
| HORIZON THERAPEUTICS PUB L HZNP | $11.6m3.52% | Added +34.5k |
| ADICET BIO INC COM | $10.1m3.08% | Added +29.9k |
| ZENTALIS PHARMACEUTICALS INC ZNTL | $9.3m2.84% | Added +11.1k |
| SAGE THERAPEUTICS INC SAGE | $8.3m2.52% | New |
| VAXCYTE INC PCVX | $7.6m2.32% | Added +20.9k |
| TRACON PHARMACEUTICALS INC COM NEW | $7.5m2.27% | Added +152.1k |
| XENON PHARMACEUTICALS INC XENE | $7.3m2.23% | Added +60.3k |
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $7.1m2.16% | New |
| SIERRA ONCOLOGY INC COM NEW | $7.0m2.12% | Reduced -351.1k |
| GOSSAMER BIO INC GOSS | $6.7m2.05% | Reduced -391.6k |
| VERTEX PHARMACEUTICALS INC VRTX | $6.5m1.98% | New |
| RIGEL PHARMACEUTICALS INC COM NEW | $6.4m1.94% | Added +1.7m |
| KARUNA THERAPEUTICS INC COM | $6.3m1.93% | New |
| BELLUS HEALTH INC NEW BLU | $6.3m1.91% | Added +863.3k |
| IMMATICS N.V IMTX | $6.2m1.90% | Added +43.8k |
| SERES THERAPEUTICS INC COM | $6.0m1.82% | Added +44.7k |
| SCPHARMACEUTICALS INC SCPH | $5.5m1.68% | Added +68.7k |
| GALAPAGOS NV LKFT | $5.4m1.65% | Unchanged |
| AMYLYX PHARMACEUTICALS INC AMLX | $5.1m1.55% | New |
| AMGEN INC AMGN | $4.8m1.47% | New |
| PFIZER INC PFE | $4.1m1.26% | New |
| BIOMARIN PHARMACEUTICAL INC BMRN | $3.9m1.17% | New |
| CHIMERIX INC CMRX | $3.9m1.17% | Added +45.8k |
| AADI BIOSCIENCE INC WHWK | $3.5m1.08% | Added +12.0k |
| INHIBRX INC INBX | $3.5m1.07% | Added +8.0k |
| INTELLIA THERAPEUTICS INC NTLA | $3.4m1.05% | New |
| REATA PHARMACEUTICALS INC RETA | $2.8m0.87% | New |
| AYALA PHARMACEUTICALS INC COM | $2.8m0.86% | Added +39.1k |
| SATSUMA PHARMACEUTICALS INC STSA | $2.5m0.76% | Added +24.1k |
| X4 PHARMACEUTICALS INC COM | $2.4m0.73% | Reduced -892.5k |
| PARDES BIOSCIENCES INC COM | $2.3m0.71% | Reduced -76.1k |
| OVID THERAPEUTICS INC OVID | $2.3m0.71% | Added +33.3k |
| SAVARA INC SVRA | $2.1m0.65% | Added +82.9k |
| KYMERA THERAPEUTICS INC KYMR | $2.1m0.64% | New |
| WAVE LIFE SCIENCES LTD 96663EUR | $2.1m0.64% | Added +54.6k |
| CABALETTA BIO INC CABA | $2.1m0.63% | Added +49.7k |
| CONNECT BIOPHARMA HLDGS LTD ADS | $2.0m0.62% | Added +415.6k |
| CLENE INC CLNN | $2.0m0.62% | Added +25.0k |
| LIQUIDIA CORPORATION LQDA | $1.8m0.53% | Reduced -81.5k |
| GLOBAL BLOOD THERAPEUTICS IN GBT | $1.7m0.53% | Reduced -114.1k |
| LYRA THERAPEUTICS INC LYRA | $1.7m0.52% | Added +27.8k |
| ALDEYRA THERAPEUTICS INC ALDX | $1.7m0.51% | New |
| FINCH THERAPEUTICS GROUP INC COM | $1.7m0.51% | Added +14.8k |
| VIKING THERAPEUTICS INC VKTX | $1.6m0.49% | Added +31.8k |
| CLOVIS ONCOLOGY INC CLVS | $1.6m0.47% | Reduced -340.3k |
| AUTOLUS THERAPEUTICS PLC AUTL | $1.6m0.47% | Reduced -172.6k |
| PROTARA THERAPEUTICS INC TARA | $1.5m0.46% | Added +17.2k |
| AILERON THERAPEUTICS INC ALRN | $1.5m0.45% | Added +138.5k |
| RENOVACOR INC COM | $1.5m0.44% | Added +381 |
| MACROGENICS INC MGNX | $1.4m0.44% | Added +8.1k |
| ELEDON PHARMACEUTICALS INC ELDN | $1.4m0.43% | Added +18.0k |
| MERUS N V MRUS | $1.4m0.43% | Added +2.8k |
| VASCULAR BIOGENICS LTD COM | $1.4m0.43% | Added +39.9k |
| CHEMOMAB THERAPEUTICS LTD SPONSORED ADS | $1.3m0.39% | Added +2.8k |
| SYNLOGIC INC COM | $1.2m0.38% | Added +36.0k |
| ANEBULO PHARMACEUTICALS INC ANEB | $1.2m0.37% | Added +8.9k |
| SYNAPTOGENIX INC COM NEW | $1.2m0.36% | Added +7.6k |
| BELLICUM PHARMACEUTICALS INC BLCM | $1.1m0.34% | Added +26.6k |
| NUVATION BIO INC NUVB | $1.1m0.34% | Added +13.3k |
| AURINIA PHARMACEUTICALS INC AUPH | $1.1m0.33% | Added +4.7k |
| PHATHOM PHARMACEUTICALS INC PHAT | $1.1m0.33% | Added +4.0k |
| CASI PHARMACEUTICALS INC CASI | $1.1m0.32% | Added +97.1k |
| DBV TECHNOLOGIES S A SPONSORED ADR | $1.0m0.32% | Added +6.8k |
| ASCENDIS PHARMA A/S SPONSORED ADR | $1.0m0.31% | Added +363 |
| BRAINSTORM CELL THERAPEUTICS COM NEW | $1.0m0.31% | Added +14.6k |
| MAXCYTE INC MXCT | $964.0k0.29% | Added +8.0k |
| VERASTEM INC COM | $956.0k0.29% | Added +40.7k |
| CORVUS PHARMACEUTICALS INC CRVS | $837.0k0.25% | Added +27.5k |
| IVERIC BIO INC OPHT | $825.0k0.25% | Added +2.6k |
| BCLS ACQUISITION CORP COM CL A | $762.0k0.23% | Added +3.5k |
| HEPION PHARMACEUTICALS INC COM | $751.0k0.23% | Added +28.9k |
| PANBELA THERAPEUTICS INC COM | $750.0k0.23% | Added +17.6k |
| QUANTUM SI INC QSI | $736.0k0.22% | Added +13.0k |
| NEXTCURE INC COM | $686.0k0.21% | Added +7.0k |
| INFLARX NV IFRX | $639.0k0.19% | Added +18.4k |
| PLIANT THERAPEUTICS INC PLRX | $636.0k0.19% | Added +4.1k |
| VISTAGEN THERAPEUTICS INC VTGN | $633.0k0.19% | Added +35.5k |
| SOLID BIOSCIENCES INC COM | $625.0k0.19% | Unchanged |
| ASTRIA THERAPEUTICS INC CATB | $619.0k0.19% | Added +4.6k |
| GEMINI THERAPEUTICS INC COM | $615.0k0.19% | Added +22.0k |
| MYMD PHARMACEUTICALS INC COM | $612.0k0.19% | Added +7.4k |
| TENAX THERAPEUTICS INC COM NEW | $596.0k0.18% | Added +40.9k |
| RELMADA THERAPEUTICS INC RLMD | $588.0k0.18% | Added +1.1k |
| KALVISTA PHARMACEUTICALS INC KALV | $586.0k0.18% | Added +3.2k |
| CYCLERION THERAPEUTICS INC COM | $585.0k0.18% | Added +24.8k |
| HARPOON THERAPEUTICS INC COM | $582.0k0.18% | Added +5.7k |
| INTERCEPT PHARMACEUTICALS IN ICPT | $572.0k0.17% | Added +584 |
| AVALO THERAPEUTICS INC COM | $554.0k0.17% | Added +45.6k |
| DIAMEDICA THERAPEUTICS INC DMAC | $553.0k0.17% | Added +12.2k |
| MUSTANG BIO INC MBIO | $551.0k0.17% | Added +40.8k |
| RENEO PHARMACEUTICALS INC COM | $546.0k0.17% | Added +10.6k |
| VTV THERAPEUTICS INC VTVT | $536.0k0.16% | Added +43.0k |
| CORBUS PHARMACEUTICALS HLDGS CRBP | $530.0k0.16% | Added +49.1k |
| KODIAK SCIENCES INC KOD | $526.0k0.16% | New |
| OTONOMY INC OTIC | $525.0k0.16% | Added +10.2k |
| ASSEMBLY BIOSCIENCES INC COM | $468.0k0.14% | Added +12.2k |
Sold out since Q4 2021
| Security | Value then |
|---|---|
| ISHARES TR IBB | $3.7m24.0k shares |
| IOVANCE BIOTHERAPEUTICS INC IOVA | $3.3m172.5k shares |
| MADRIGAL PHARMACEUTICALS INC MDGL | $2.0m23.7k shares |
| AMICUS THERAPEUTICS INC FOLD | $1.9m164.2k shares |
| ODONATE THERAPEUTICS INC | $1.8m1.3m shares |
| RAFAEL HLDGS INC RFL | $370.0k72.5k shares |
| ARENA PHARMACEUTICALS INC ARNA | $200.0k2.2k shares |
| BRIDGEBIO PHARMA INC BBIO | $25.0k1.5k shares |
| BAUDAX BIO INC | $21.0k95.1k shares |
| FRAZIER LIFESCIENCES ACQU CO | $9.0k941 shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR SER TR XBI · Call | $84.1m935.6k shares | Added |
| NEUROCRINE BIOSCIENCES INC NBIX · Call | $40.3m429.6k shares | New |
| BIOMARIN PHARMACEUTICAL INC BMRN · Call | $24.2m313.8k shares | Added |
| AMGEN INC AMGN · Call | $24.2m100.0k shares | New |
| BIOGEN INC BIIB · Call | $23.6m112.2k shares | New |
| ALNYLAM PHARMACEUTICALS INC ALNY · Call | $22.1m135.2k shares | Reduced |
| REATA PHARMACEUTICALS INC RETA · Put | $21.3m649.6k shares | Added |
| CELLDEX THERAPEUTICS INC NEW CLDX · Put | $20.3m595.5k shares | Added |
| ALNYLAM PHARMACEUTICALS INC ALNY · Put | $19.2m117.8k shares | New |
| UNITED THERAPEUTICS CORP DEL UTHR · Call | $17.9m100.0k shares | New |
| HORIZON THERAPEUTICS PUB L HZNP · Call | $16.6m158.1k shares | Reduced |
| CELLDEX THERAPEUTICS INC NEW CLDX · Call | $11.7m344.1k shares | Reduced |
| BICYCLE THERAPEUTICS PLC BCYC · Call | $11.6m264.7k shares | New |
| GILEAD SCIENCES INC GILD · Put | $10.8m181.3k shares | New |
| GILEAD SCIENCES INC GILD · Call | $10.8m181.3k shares | New |
| ATHIRA PHARMA INC Call | $10.6m784.2k shares | Reduced |
| APELLIS PHARMACEUTICALS INC APLS · Call | $8.9m175.1k shares | Reduced |
| SAGE THERAPEUTICS INC SAGE · Call | $8.3m250.0k shares | Added |
| ARCUS BIOSCIENCES INC RCUS · Call | $4.7m150.0k shares | New |
| BICYCLE THERAPEUTICS PLC BCYC · Put | $4.7m106.6k shares | New |
| KEZAR LIFE SCIENCES INC Call | $4.7m280.8k shares | Added |
| BLUEPRINT MEDICINES CORP BPMC · Call | $4.1m64.0k shares | New |
| PROTAGONIST THERAPEUTICS INC PTGX · Call | $3.8m160.7k shares | Added |
| AMYLYX PHARMACEUTICALS INC AMLX · Call | $3.2m250.0k shares | New |
| ATHIRA PHARMA INC Put | $2.7m200.0k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| NEXTCURE INC NXTC · 13G · filed 2026-08-14 | 10.0%≈ $804.3k |
| CNS PHARMACEUTICALS INC CNSP · 13G · filed 2026-08-14 | 9.9%≈ $704.0k |
| TRAWS PHARMA INC TRAW · 13G · filed 2026-08-14 | 9.5%≈ $1.3m |
| QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-08-14 | 9.0%≈ $1.7m |
| PELTHOS THERAPEUTICS INC PTHS · 13G · filed 2026-05-15 | 7.7%≈ $7.3m |
| CHANNEL THERAPEUTICS CORPORA 13G · filed 2025-02-14 | 7.3% |
| CONNECT BIOPHARMA HLDGS LTD 13G · filed 2026-08-14 | 6.9% |
| LIPOCINE INC NEW LPCN · 13G · filed 2026-05-15 | 6.3% |